US wards off generic competition, while Japan considers embracing it

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1492, 2005-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Topiramate wards off cost headache . . .

Inpharma, Vol. 1, Iss. 1537, 2006-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Topiramate wards off cost headache . . .

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 502, 2006-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

US generic approvals

Inpharma, Vol. 1, Iss. 1488, 2005-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Generic Drug Regulation in the US Under the Hatch-Waxman Act: A Balance Between Competition and Innovation or Confusion and Intrigue?

By Milne C-P. Cairns C.

Pharmaceutical Development and Regulation, Vol. 1, Iss. 1, 2003-01 ,pp. : 11-27

Adis International

Access to resources Recommend Favorite

Generic pamidronic acid approved in the US.

Inpharma, Vol. 1, Iss. 1653, 2008-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite